Prognostic Value of sST2 in Heart Failure

被引：19

作者：

Sciatti, Edoardo ^{[1
]}

Merlo, Anna ^{[2
]}

Scangiuzzi, Claudio ^{[2
]}

Limonta, Raul ^{[2
]}

Gori, Mauro ^{[1
]}

D'Elia, Emilia ^{[1
]}

Aimo, Alberto ^{[3
,4
]}

Vergaro, Giuseppe ^{[3
,4
]}

Emdin, Michele ^{[3
,4
]}

Senni, Michele ^{[1
,2
]}

机构：

[1] ASST Papa Giovanni XXIII, Cardiol Unit, I-24127 Bergamo, Italy

[2] Univ Milano Bicocca, Sch Med & Surg, I-20126 Milan, Italy

[3] Scuola Super Sant Anna, Hlth Sci Interdisciplinary Ctr, I-56127 Pisa, Italy

[4] Fdn Toscana G Monasterio, I-56124 Pisa, Italy

来源：

JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 12期

关键词：

ST2; heart failure; biomarker; natriuretic peptide; prognosis; SENSITIVITY TROPONIN-T; SOLUBLE ST2; NATRIURETIC PEPTIDE; MYOCARDIAL FIBROSIS; RISK STRATIFICATION; BIOMARKERS; MORTALITY; RECEPTOR; PREDICTION; MANAGEMENT;

D O I：

10.3390/jcm12123970

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In recent years, there has been growing interest in the risk stratification for heart failure, and the use of multiple biomarkers to identify different pathophysiological processes associated with this condition. One such biomarker is soluble suppression of tumorigenicity-2 (sST2), which has shown some potential for integration into clinical practice. sST2 is produced by both cardiac fibroblasts and cardiomyocytes in response to myocardial stress. Other sources of sST2 are endothelial cells of the aorta and coronary arteries and immune cells such as T cells. Indeed, ST2 is also associated with inflammatory and immune processes. We aimed at reviewing the prognostic value of sST2 in both chronic and acute heart failure. In this setting, we also provide a flowchart about its potential use in clinical practice.

引用

页数：10

共 50 条

[21] sST2 Protein Serum Levels in Patients with Chronic Heart Failure
Tokmachev, R. E.
Kravchenko, A. Ya
Budnevsky, A., V
Ovsyannikov, E. S.
Chernik, T. A.
Tokmachev, E., V
Shkatova, Ya S.
INTERNATIONAL JOURNAL OF BIOMEDICINE, 2020, 10 (04) : 342 - 346
[22] The prognostic value of sST2 in connective tissue disease patients with pulmonary hypertension
Ye, Huangshu
Wu, Qianwen
Zhang, Ning
Shi, Jing
Zhang, Haifeng
Wang, Qiang
Zhang, Miaojia
Sun, Xiaoxuan
RHEUMATOLOGY, 2022, 61 (10) : 3989 - 3996
[23] Multimarker approach including CRP, sST2 and GDF-15 for prognostic stratification in stable heart failure
Kuster, Nils
Huet, Fabien
Dupuy, Anne-Marie
Akodad, Mariama
Battistella, Pascal
Agullo, Audrey
Leclercq, Florence
Kalmanovich, Eran
Meilhac, Alexandra
Aguilhon, Sylvain
Cristol, Jean-Paul
Roubille, Francois
ESC HEART FAILURE, 2020, 7 (05): : 2230 - 2239
[24] RETRACTED: Correlation between Serum LP-PLA2 and sST2 Levels and the Condition of Patients with Acute Heart Failure and Their Prognostic Value (Retracted Article)
Zhu, Junguo
Ruan, Zhongbao
Zhu, Li
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
[25] Chronic obstructive pulmonary disease in heart failure: impact on circulating levels and prognostic value of NT-proBNP, HS-TNTand SST2
Vergaro, Giuseppe
Aimo, Alberto
Januzzi, James L.
Richards, Mark
Lam, Carolyn
Latini, Roberto
Anand, Inder
Cohn, Jay N.
Ueland, Thor
Gullestad, Lars
Aukrust, Pal
Brunner-la Rocca, Hans-Peter
Bayes-Genis, Antoni
Lupon, Josep
De Boer, Rudolf
Takeishi, Yasuchika
Egstrup, Michael
Gustafsson, Ida
Gaggin, Hanna
Eggers, Kai M.
Huber, Kurt
Troughton, Richard
Passino, Claudio
Emdin, Michele
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N88 - N88
[26] sST2 for Outcome Prediction in Acute Heart Failure Which Is the Best Cutoff?
Aimo, Alberto
Maisel, Alan S.
Castiglione, Vincenzo
Emdin, Michele
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (03) : 478 - 479
[27] The inflammatory markers sST2, HSP27 and hsCRP as a prognostic biomarker panel in chronic heart failure patients
Traxler, Denise
Zimmermann, Matthias
Simader, Elisabeth
Veraar, Cecilia M.
Moser, Bernhard
Mueller, Thomas
Mildner, Michael
Dannenberg, Varius
Lainscak, Mitja
Jug, Borut
Ankersmit, Hendrik J.
CLINICA CHIMICA ACTA, 2020, 510 : 507 - 514
[28] Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
Podzolkov, V., I
Dragomiretskaya, N. A.
Tolmacheva, A., V
Shvedov, I. I.
Ivannikov, A. A.
Yu, Akyol, V
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (04) : 310 - 319
[29] sSt2 Level at Decompensated Chronic Heart Failure in Patients with Dilated Cardiomyopathy
Gulomov, Khumoyun A.
Abdullaev, Timur A.
Tsoi, Igor A.
Ziyaeva, Adolat, V
INTERNATIONAL JOURNAL OF BIOMEDICINE, 2022, 12 (02) : 222 - 226
[30] Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
Pan, Wei
Yang, Donghui
Yu, Peng
Yu, Huizhen
BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)

← 1 2 3 4 5 →